Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; A Petzer; S Burgstaller; D Voskova; D Rossmann; M Balic; D Egle; H Rumpold; CF Singer; E Petru; Thomas Melchardt; H Ulmer; Brigitte Mlineritsch; Richard Greil

doi:10.1158/1538-7445.SABCS18-OT3-07-01

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

Gabriel Rinnerthaler, Simon Peter Gampenrieder, A Petzer, S Burgstaller, D Voskova, D Rossmann, M Balic, D Egle, H Rumpold, CF Singer, E Petru, Thomas Melchardt, H Ulmer, Brigitte Mlineritsch, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	79
Issue number	4
DOIs	https://doi.org/10.1158/1538-7445.SABCS18-OT3-07-01
Publication status	Published - 2019
Event	San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 4 Dec 2018 → 8 Dec 2018

Access to Document

10.1158/1538-7445.SABCS18-OT3-07-01

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Petzer, A., Burgstaller, S., Voskova, D., Rossmann, D., Balic, M., Egle, D., Rumpold, H., Singer, CF., Petru, E., Melchardt, T., Ulmer, H., Mlineritsch, B., & Greil, R. (2019). Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). CANCER RESEARCH , 79(4). https://doi.org/10.1158/1538-7445.SABCS18-OT3-07-01

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Petzer, A et al. / Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). In: CANCER RESEARCH 2019 ; Vol. 79, No. 4.

@article{fee1484852474589b2b56513c3bd5cee,

title = "Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)",

author = "Gabriel Rinnerthaler and Gampenrieder, {Simon Peter} and A Petzer and S Burgstaller and D Voskova and D Rossmann and M Balic and D Egle and H Rumpold and CF Singer and E Petru and Thomas Melchardt and H Ulmer and Brigitte Mlineritsch and Richard Greil",

year = "2019",

doi = "10.1158/1538-7445.SABCS18-OT3-07-01",

language = "English",

volume = "79",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "4",

note = "San Antonio Breast Cancer Symposium ; Conference date: 04-12-2018 Through 08-12-2018",

}

Rinnerthaler, G , Gampenrieder, SP, Petzer, A, Burgstaller, S, Voskova, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B & Greil, R 2019, 'Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)', CANCER RESEARCH , vol. 79, no. 4. https://doi.org/10.1158/1538-7445.SABCS18-OT3-07-01

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). / Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter; Petzer, A et al.
In: CANCER RESEARCH , Vol. 79, No. 4, 2019.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Petzer, A

AU - Burgstaller, S

AU - Voskova, D

AU - Rossmann, D

AU - Balic, M

AU - Egle, D

AU - Rumpold, H

AU - Singer, CF

AU - Petru, E

AU - Melchardt, Thomas

AU - Ulmer, H

AU - Mlineritsch, Brigitte

AU - Greil, Richard

PY - 2019

Y1 - 2019

U2 - 10.1158/1538-7445.SABCS18-OT3-07-01

DO - 10.1158/1538-7445.SABCS18-OT3-07-01

M3 - Abstract (Journal)

SN - 0008-5472

VL - 79

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 4

T2 - San Antonio Breast Cancer Symposium

Y2 - 4 December 2018 through 8 December 2018

ER -

Rinnerthaler G , Gampenrieder SP, Petzer A, Burgstaller S, Voskova D, Rossmann D et al. Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). CANCER RESEARCH . 2019;79(4). doi: 10.1158/1538-7445.SABCS18-OT3-07-01